Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edouard Auclin

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Cancers|July 20, 2021
<i>TP53</i> Mutation as a Prognostic and Predictive Marker in Sarcoma: Pooled Analysis of MOSCATO and ProfiLER Precision Medicine TrialsElise F Nassif, Edouard Auclin, Rastilav Bahleda, et al.
Cancers|April 12, 2022
Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective StudyZoé Guillaume, Emeline Colomba, Jonathan Thouvenin, et al.
British Journal of Cancer|November 26, 2019
Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancerWungki Park, Laura Mezquita, Naoyuki Okabe, et al.
Clinics and Research in Hepatology and Gastroenterology|April 29, 2019
Characteristic and outcomes of patients with pathologic complete response after preoperative treatment in borderline and locally advanced pancreatic adenocarcinoma: An AGEO multicentric retrospective cohortHampig Kourie, Edouard Auclin, Antonio Sa Cunha, et al.
Clinical Genitourinary Cancer|February 21, 2017
Prediction of Everolimus Toxicity and Prognostic Value of Skeletal Muscle Index in Patients With Metastatic Renal Cell CarcinomaEdouard Auclin, Camille Bourillon, Eleonora De Maio, et al.
European Journal of Cancer (Oxford, England : 1990)|January 8, 2019
Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinomaMarie Auvray, Edouard Auclin, Philippe Barthelemy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 3, 2019
Carcinoembryonic Antigen Levels and Survival in Stage III Colon Cancer: <i>Post hoc</i> Analysis of the MOSAIC and PETACC-8 TrialsEdouard Auclin, Julien Taieb, Come Lepage, et al.
Cancers|December 17, 2024
Association of Lung Immune Prognostic Index (LIPI) with Disease Control Rate and Progression-Free Survival in Patients with Soft-Tissue Sarcoma Treated with Immunotherapy in Early-Phase TrialsMarianne Zoghbi, Brina A Patel, Matthieu Roulleaux Dugage, et al.
Clinical Lung Cancer|June 2, 2019
Indoor Radon in EGFR- and BRAF-Mutated and ALK-Rearranged Non-Small-Cell Lung Cancer PatientsLaura Mezquita, Amparo Benito, Alberto Ruano-Raviña, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 2, 2021
First-line chemotherapy with raltitrexed in metastatic colorectal cancer: an Association des Gastro-entérologues Oncologues (AGEO) multicentre studyClaire Gallois, Emilie Hafliger, Edouard Auclin, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Cancers|July 20, 2021
<i>TP53</i> Mutation as a Prognostic and Predictive Marker in Sarcoma: Pooled Analysis of MOSCATO and ProfiLER Precision Medicine TrialsElise F Nassif, Edouard Auclin, Rastilav Bahleda, et al.
Cancers|April 12, 2022
Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective StudyZoé Guillaume, Emeline Colomba, Jonathan Thouvenin, et al.
British Journal of Cancer|November 26, 2019
Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancerWungki Park, Laura Mezquita, Naoyuki Okabe, et al.
Clinics and Research in Hepatology and Gastroenterology|April 29, 2019
Characteristic and outcomes of patients with pathologic complete response after preoperative treatment in borderline and locally advanced pancreatic adenocarcinoma: An AGEO multicentric retrospective cohortHampig Kourie, Edouard Auclin, Antonio Sa Cunha, et al.
Clinical Genitourinary Cancer|February 21, 2017
Prediction of Everolimus Toxicity and Prognostic Value of Skeletal Muscle Index in Patients With Metastatic Renal Cell CarcinomaEdouard Auclin, Camille Bourillon, Eleonora De Maio, et al.
European Journal of Cancer (Oxford, England : 1990)|January 8, 2019
Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinomaMarie Auvray, Edouard Auclin, Philippe Barthelemy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 3, 2019
Carcinoembryonic Antigen Levels and Survival in Stage III Colon Cancer: <i>Post hoc</i> Analysis of the MOSAIC and PETACC-8 TrialsEdouard Auclin, Julien Taieb, Come Lepage, et al.
Cancers|December 17, 2024
Association of Lung Immune Prognostic Index (LIPI) with Disease Control Rate and Progression-Free Survival in Patients with Soft-Tissue Sarcoma Treated with Immunotherapy in Early-Phase TrialsMarianne Zoghbi, Brina A Patel, Matthieu Roulleaux Dugage, et al.
Clinical Lung Cancer|June 2, 2019
Indoor Radon in EGFR- and BRAF-Mutated and ALK-Rearranged Non-Small-Cell Lung Cancer PatientsLaura Mezquita, Amparo Benito, Alberto Ruano-Raviña, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 2, 2021
First-line chemotherapy with raltitrexed in metastatic colorectal cancer: an Association des Gastro-entérologues Oncologues (AGEO) multicentre studyClaire Gallois, Emilie Hafliger, Edouard Auclin, et al.
Pageof 9